Plasma Progastrin-releasing peptide (ProGRP) level well predicts the degree and duration of PSA response in patients with metastatic castration-resistant prostate cancer underwent enzalutamide

Autor:	M. Yashi, M. Yokoyama, H. Fuchizawa, N. Okubo, R. Kurashina, K. Takei, I. Suzuki, K. Sakamoto, A. Nukui, Y. Fukabori, T. Kamai
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Diseases of the genitourinary system. Urology RC870-923 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	European Urology Open Science, Vol 19, Iss , Pp e895- (2020)
Druh dokumentu:	article
ISSN:	2666-1683
DOI:	10.1016/S2666-1683(20)33178-5
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/5e72cd62c7874a5297c7b04a0f0b3127 Zobrazit plný text záznamu View record in DOAJ